The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial ; volume:20 ; number:1 ; day:17 ; month:8 ; year:2020 ; pages:1-6 ; date:12.2020
BMC cancer ; 20, Heft 1 (17.8.2020), 1-6, 12.2020
- Creator
-
Higurashi, Takuma
Arimoto, Jun
Ashikari, Keiichi
Takatsu, Tomohiro
Misawa, Noboru
Yoshihara, Tsutomu
Matsuura, Tetsuya
Fuyuki, Akiko
Ohkubo, Hidenori
Nakajima, Atsushi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-07266-6
- URN
-
urn:nbn:de:101:1-2020100900030330871569
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Higurashi, Takuma
- Arimoto, Jun
- Ashikari, Keiichi
- Takatsu, Tomohiro
- Misawa, Noboru
- Yoshihara, Tsutomu
- Matsuura, Tetsuya
- Fuyuki, Akiko
- Ohkubo, Hidenori
- Nakajima, Atsushi
- SpringerLink (Online service)
Other Objects (12)
Detection of aberrant crypt foci with image-enhanced endoscopy
Molecular detection of CD44v6 on aberrant crypt foci by confocal laser endoscopy
Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients
Molecular imaging of aberrant crypt foci in the human colon targeting glutathione S-transferase P1-1
Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
Magnification endoscopy to detect dysplastic aberrant crypt foci in Mexican patients with high risk for colorectal cancer
Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine
Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat
LINE-1 hypomethylation is neither present in rectal aberrant crypt foci nor associated with field defect in sporadic colorectal neoplasia
The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial
Erratum to: Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat
Dietary Energy Intake and Presence of Aberrant Crypt Foci Are Associated with Phospholipid, Purine, and Taurine Metabolite Abundances in C57BL/6N Mouse Colon
Detection of aberrant crypt foci with image-enhanced endoscopy
Molecular detection of CD44v6 on aberrant crypt foci by confocal laser endoscopy
Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients
Molecular imaging of aberrant crypt foci in the human colon targeting glutathione S-transferase P1-1
Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
Magnification endoscopy to detect dysplastic aberrant crypt foci in Mexican patients with high risk for colorectal cancer
Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine
Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat
LINE-1 hypomethylation is neither present in rectal aberrant crypt foci nor associated with field defect in sporadic colorectal neoplasia
The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial
Erratum to: Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat
Dietary Energy Intake and Presence of Aberrant Crypt Foci Are Associated with Phospholipid, Purine, and Taurine Metabolite Abundances in C57BL/6N Mouse Colon
Detection of aberrant crypt foci with image-enhanced endoscopy
Molecular detection of CD44v6 on aberrant crypt foci by confocal laser endoscopy
Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients
Molecular imaging of aberrant crypt foci in the human colon targeting glutathione S-transferase P1-1
Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
Magnification endoscopy to detect dysplastic aberrant crypt foci in Mexican patients with high risk for colorectal cancer
Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine
Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat
LINE-1 hypomethylation is neither present in rectal aberrant crypt foci nor associated with field defect in sporadic colorectal neoplasia
The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial
Erratum to: Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat